IPP Bureau
Indian scientists develop AI-enabled tech for biomedical diagnostic applications
By IPP Bureau - May 28, 2026
The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention
Remidio’s InstaEyeClinic wins first position at Andhra Pradesh MedTech Innovation Challenge
By IPP Bureau - May 28, 2026
The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient
Cadila Pharma launches Subhadra Syrup for menstrual health support
By IPP Bureau - May 28, 2026
The syrup launched by company's Chezgreen division is designed to provide supportive care in managing common menstrual concerns such as amenorrhea, dysmenorrhea, and menorrhagia
Ashish Mukkirwar appointed CFO of Jubilant Pharmova
By IPP Bureau - May 27, 2026
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
Glenmark Pharma appoints Shisher Chowksey as Head of Marketing
By IPP Bureau - May 27, 2026
In his new role, Shisher will lead Glenmark’s marketing initiatives, focusing on strengthening brand positioning, driving market expansion, and accelerating growth
Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz
By IPP Bureau - May 27, 2026
The company highlighted continued demand strength and pricing resilience despite global disruptions
Novo Nordisk study exposes “hidden” inflammation driving cardio risk despite care
By IPP Bureau - May 27, 2026
POSEIDON is among the largest global datasets to quantify this residual inflammatory burden
Tecan launches direct India operations
By IPP Bureau - May 27, 2026
The move signals a major expansion milestone for the Swiss laboratory automation company
Siegfried locks in CHF 200m bond deal as investors bet big on pharma outsourcing boom
By IPP Bureau - May 27, 2026
The bonds, due June 15, 2030, were placed with Swiss investors under the joint lead of UBS and Zürcher Kantonalbank
Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention
By IPP Bureau - May 27, 2026
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
Align Tech to open $200M manufacturing facility in Hyderabad aiming 300+ jobs
By IPP Bureau - May 27, 2026
The new facility marks Align’s first manufacturing presence in India and its fourth globally
Sun's cancer drug shines delivering 50% response rate with long-lasting tumor control
By IPP Bureau - May 27, 2026
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
President of India confers Padma Shri Award on Dr. P. Vijay Anand Reddy
By IPP Bureau - May 26, 2026
The director of Apollo Cancer Centres in Hyderabad and founder of CURE Foundation honored for his contributions to cancer awareness and treatment
Dr. Ramesh Juneja joins Alembic Pharmaceuticals as Head – India Business
By IPP Bureau - May 26, 2026
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
Amgen appoints Madhur Sarin as Director – AI & Data Science COE
By IPP Bureau - May 26, 2026
Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains
